It would be predicted that CAR T cells manufactured with interleukin-15 would exhibit an increased release of key effector cytokines, such as Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α), upon antigen stimulation when compared to T cells manufactured without interleukin-15.